Expression of myeloproliferative markers in patients with polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis
| . | EECs . | PRV-1 . | c-Mpl . | V617F JAK2 . | ||||
|---|---|---|---|---|---|---|---|---|
| Positive . | % . | Positive . | % . | Low . | % . | Positive . | % . | |
| PV, n = 41 | 31 | 76 | 33 | 80 | 37 | 90 | 33 | 81 |
| ET, n = 34 | 26 | 76 | 27 | 79 | 27 | 79 | 15 | 44 |
| IM, n = 5 | 3 | 60 | 0 | 0 | 5 | 100 | 3 | 60 |
| . | EECs . | PRV-1 . | c-Mpl . | V617F JAK2 . | ||||
|---|---|---|---|---|---|---|---|---|
| Positive . | % . | Positive . | % . | Low . | % . | Positive . | % . | |
| PV, n = 41 | 31 | 76 | 33 | 80 | 37 | 90 | 33 | 81 |
| ET, n = 34 | 26 | 76 | 27 | 79 | 27 | 79 | 15 | 44 |
| IM, n = 5 | 3 | 60 | 0 | 0 | 5 | 100 | 3 | 60 |
The number of evaluated patients is listed for each condition.